University of Kansas researchers who wish to learn how to prepare proposals for the National Science Foundation are invited to attend a seminar Feb. 3 at the Bioscience & Technology Business Center in Lawrence.
The University of Kansas will soon have a new leader for its research enterprise.
The medical device industry incorporates research from dozens of academic areas, ranging from engineering and medicine to pharmacy and industrial design.
The University of Kansas is partnering with a leading entrepreneur development program to translate more KU technologies into new products and startup companies.
The University of Kansas and Reata Pharmaceuticals of Irving, Texas, have completed a major licensing agreement for a portfolio of drug technologies invented by two KU professors. The researchers are exploring the potential use of “novologues” for treating a common complication of diabetes: diabetic peripheral neuropathy (DPN).